Concepedia

Sandro Belvedere

SB

Statistics

Publications

15

Citations

597

H-Index

13

Active since

1998

Affiliations

Columbia University(Current)

Multimeric Biotherapeutics (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Sapienza University of Rome

Sandro Belvedere is an author at Columbia University specializing in life sciences, biochemistry, and pharmacology.

ORCID

Publications per year

1998–2022

15

Publications

15

Catalytic Oxidations of Steroid Substrates by Artificial Cytochrome P-450 Enzymes

Jerry Yang, Bartolo Gabriele, Sandro Belvedere et al. · The Journal of Organic Chemistry · 2002 · 186 citations

, , +17

The chelate effect in binding, catalysis, and chemotherapy

Ronald Breslow, Sandro Belvedere, Leland Gershell et al. · Pure and Applied Chemistry · 2000 · 70 citations · Full text

, , +17

Aminosuberoyl hydroxamic acids (ASHAs): A potent new class of HDAC inhibitors

Sandro Belvedere, David J. Witter, Jiaming Yan et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 44 citations · Full text

, , +9

Catalytic hydroxylation of steroids by cytochrome P-450 mimics. Hydroxylation at C-9 with novel catalysts and steroid substrates

Ronald Breslow, Jiaming Yan, Sandro Belvedere · Tetrahedron Letters · 2002 · 41 citations

, , +17

Benzo[b]thiophene-based histone deacetylase inhibitors

David J. Witter, Sandro Belvedere, Liqiang Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 39 citations · Full text

, , +9

1–5 of 15